About this trial
During the transition phase from early intervention to primary education (4.5 years to 8.11 years), children with special needs may encounter difficulties in using digital learning media. The investigators intend to apply the TRIZ analysis method to enhance children's participation in learning. Additionally, the investigators plan to design a preliminary model of learning aids and conduct a trial.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
the caregiver of a child with special needs in early care;
the caregiver or child has trouble using electronic devices or needs;
the child can cooperate with the full questionnaire;
the child with special needs in early care attends school. Analysis of Assistive Device Trial part
Disqualifiers
The child is younger than 4.5 years old or older than 9 years old;
The caregiver is unable to communicate and read in Chinese.
Children younger than 6 years or older than 9 years of age;
Children who are unable to recognize Zhuyin (Bopomofo) phonetic symbols.
Trial design
Treatments tested in this trial
Digital Learning Aids
Combination productRecruitment is currently underway for special children undergoing outpatient early intervention. Among the recruited participants, five children between the ages of 6 and 9, who are receiving early intervention, were screened. After obtaining their consent to participate in this study, their basic information was recorded, including gender, age, education, diagnosis, Movement Assessment Battery for Children (MABC-2), Visual-Motor Integration (VMI) test, and Children's ABILHAND questionnaire for manual ability. Once the collection of basic information is completed, a trial of digital aids will be conducted, and a trial feedback questionnaire will be administered. The trial period will consist of a 20-minute session and 2-3 sessions (per week) of home (or therapy room) use.
Treatment groups
Trial outcomes
This trial has no outcomes listed.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Taipei Medical University Shuang Ho Hospital
Lead sponsor
Taipei Medical University
Collaborator